Rapport Therapeutics, Inc. RAPP Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s interest income?
- Rapport Therapeutics, Inc. (RAPP) reported interest income of $4.36M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s interest income changed year-over-year?
- Rapport Therapeutics, Inc.'s interest income increased by 43.1% year-over-year, from $3.05M to $4.36M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s interest income?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s interest income has grown at a 132.1% compound annual growth rate (CAGR), from $2.53M to $13.62M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.